The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction
Abstract
&NA; Tumor metastasis is the primary factor causing death of cancer patients and it is a study emphasis in cancer treatment to suppress tumor metastasis by inhibiting glycolysis, which is the main way of energy supply for cell mobility in tumor. In the present study, we aimed to explore the effect of quercetin, a bioactive flavonoid, on tumor metastasis and cell glycolysis and its related functionary mechanism in breast cancer progression. Firstly, trans‐well invasion assay and wound healing assay indicated that quercetin effectively suppressed cell mobility. The corresponding western blot revealed that quercetin treatment down‐regulated the expression of cell migration marker proteins, such as matrix metalloproteinase 2 (MMP‐2), MMP‐9 and vascular endothelial growth factor (VEGF). The further experiments exhibited that quercetin successfully blocked cell glycolysis by inhibiting the level of glucose uptake and the production of lactic acid, and also decreased the level of glycolysis‐related proteins Pyruvate kinase M2 (PKM2), Glucose transporter1(GLUT1) and Lactate dehydrogenase A (LDHA). The above results revealed that quercetin might inhibit glycolysis to limit the migration of tumor cells by reducing the acidity of the tumor microenvironment. Moreover, our further investigation showed that quercetin induced obvious autophagy via inactivating the Akt‐mTOR pathway. At the same time, the application of autophagy inhibitor 3‐MA and Akt‐mTOR pathway inducer IGF‐1 further demonstrated that quercetin exerted inhibiting effect on cell mobility and glycolysis through Akt‐mTOR pathway mediated autophagy induction. At last, the in vivo experiments also showed that quercetin treatment could suppress tumor growth and metastasis, inhibit glycolysis and induce autophagy through the inhibition of p‐AKT/AKT. Taken together, we firstly revealed that quercetin suppressed the progression of breast cancer by inhibiting cell mobility and glycolysis through Akt‐mTOR pathway mediated autophagy induction and may provide a potential therapeutic target for breast cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Yang, Q., Wang, X., Tang, C., Chen, X., & He, J. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3941 · Cited by 70
RetractedYang, Q., Wang, X., Tang, C., Chen, X., & He, J. (2021) · International Journal of Oncology · doi:10.3892/ijo.2021.5206 · Cited by 60
RetractedGlobal cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.
Brown, J. M., & Giaccia, A. J. (1998) · PubMed · Cited by 1,748
Autophagy maintains stemness by preventing senescence
García-Prat, L., Martínez-Vicente, M., Perdiguero, E., Ortet, L., Rodríguez-Ubreva, J., Rebollo, E., Ruiz-Bonilla, V., Gutarra, S., Ballestar, E., Serrano, A. L., et al. (2016) · Nature · doi:10.1038/nature16187 · Cited by 1,355
Oncogenic PI3K deregulates transcription and translation
Bader, A. G., Kang, S., Zhao, L., & Vogt, P. K. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1753 · Cited by 798
A Mitochondrial Switch Promotes Tumor Metastasis
Porporato, P. E., Payen, V. L., Pérez-Escuredo, J., De Saedeleer, C. J., Danhier, P., Copetti, T., Dhup, S., Tardy, M., Vazeille, T., Bouzin, C., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.043 · Cited by 571
Global cancer control: responding to the growing burden, rising costs and inequalities in access
Prager, G. W., Braga, S., Bystricky, B., Qvortrup, C., Criscitiello, C., Esin, E., Sonke, G. S., Martínez, G., Frenel, J.-S., Karamouzis, M., et al. (2018) · ESMO Open · doi:10.1136/esmoopen-2017-000285 · Cited by 310
Jiao, L., Zhang, H.-L., Li, D.-D., Yang, K.-L., Tang, J., Li, X., Ji, J., Yu, Y., Wu, R.-Y., Ravichandran, S., et al. (2018) · Autophagy · doi:10.1080/15548627.2017.1381804 · Cited by 264
Li, L., Kang, L., Zhao, W., Feng, Y., Liu, W., Wang, T., Mai, H., Huang, J., Chen, S., Liang, Y., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.04.034 · Cited by 207
Acid treatment of melanoma cells selects for invasive phenotypes
Moellering, R. E., Black, K. C., Krishnamurty, C., Baggett, B. K., Stafford, P., Rain, M., Gatenby, R. A., & Gillies, R. J. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9145-7 · Cited by 205
Zhang, L. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.845 · Cited by 191
Inhibition of autophagy promotes metastasis and glycolysis by inducing ROS in gastric cancer cells
Qin, W., Li, C., Zheng, W., Guo, Q., Zhang, Y., Kang, M., Zhang, B., Yang, B., Li, B., Yang, H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5674 · Cited by 172
Li, S., Yuan, S., Zhao, Q., Wang, B., Wang, X., & Li, K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.055 · Cited by 171
GLUT1 regulates cell glycolysis and proliferation in prostate cancer
Xiao, H., Wang, J., Yan, W., Cui, Y., Chen, Z., Gao, X., Wen, X., & Chen, J. (2018) · The Prostate · doi:10.1002/pros.23448 · Cited by 167
Sugar and fat – that's where it's at: metabolic changes in tumors
Young, C. D., & Anderson, S. M. (2008) · Breast Cancer Research · doi:10.1186/bcr1852 · Cited by 162
Xintaropoulou, C., Ward, C., Wise, A., Marston, H., Turnbull, A., & Langdon, S. P. (2015) · Oncotarget · doi:10.18632/oncotarget.4499 · Cited by 159
Inhibition of LDHA suppresses tumor progression in prostate cancer
Xian, Z., Liu, J., Chen, Q.-K., Chen, H., Ye, C., Xue, J., Yang, H., Li, J., Liu, X., & Kuang, S. (2015) · Tumor Biology · doi:10.1007/s13277-015-3540-x · Cited by 150
Wu, Q., Needs, P. W., Lu, Y., Kroon, P. A., Ren, D., & Yang, X. (2018) · Food & Function · doi:10.1039/c7fo01964e · Cited by 134
Kee, J., Han, Y., Kim, D., Mun, J., Park, J., Jeong, M., Um, J., & Hong, S. (2016) · Phytomedicine · doi:10.1016/j.phymed.2016.09.011 · Cited by 127
Antitumor activities of Quercetin and Green Tea in xenografts of human leukemia HL60 cells
Calgarotto, A. K., Maso, V., Franchi, G. C., Nowill, A. E., Filho, P. L., Vassallo, J., & Saad, S. T. O. (2018) · Scientific Reports · doi:10.1038/s41598-018-21516-5 · Cited by 91
Metabolism and Its Sequelae in Cancer Evolution and Therapy
Gillies, R. J., & Gatenby, R. A. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000102 · Cited by 81
Maurya, A. K., & Vinayak, M. (2015) · Nutrition and Cancer · doi:10.1080/01635581.2015.990574 · Cited by 76
Feng, J., Song, D., Jiang, S., Yang, X., Ding, T., Zhang, H., Luo, J., Liao, J., & Yin, Q. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.044 · Cited by 75
Sturza, A., Pavel, I. Z., Ancușa, S., Danciu, C., Dehelean, C. A., Duicu, O., & Muntean, D. M. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3296-x · Cited by 38
Identification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma
White, N. M. A., Newsted, D., Masui, O., Romaschin, A. D., Siu, K. W. M., & Yousef, G. M. (2013) · Tumor Biology · doi:10.1007/s13277-013-1245-6 · Cited by 32
Down‐regulation of PKM 2 enhances anticancer efficiency of THP on bladder cancer
Su, Q., Tao, T., Tang, L., Deng, J., Darko, K. O., Zhou, S., Peng, M., He, S., Zeng, Q., Chen, A. F., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13571 · Cited by 31
Cited by
Xiang, Y., Guo, Z., Zhu, P., Chen, J., & Huang, Y. (2019) · Cancer Medicine · doi:10.1002/cam4.2108 · Cited by 752
The anti-cancer effect of quercetin: molecular implications in cancer metabolism
Reyes-Farias, M., & Carrasco-Pozo, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133177 · Cited by 689
“Quercetin (30 μM) also has been shown to decrease LDH-A protein levels in breast cancer, MDA-MB-231, and MCF-7 cells [64].”
BackgroundInfluentialTherapeutic Potential of Quercetin: New Insights and Perspectives for Human Health
Salehi, B., Machin, L., Monzote, L., Sharifi-Rad, J., Ezzat, S. M., Salem, M. A., Merghany, R. M., El Mahdy, N. M., Kılıç, C. S., Sytar, O., et al. (2020) · ACS Omega · doi:10.1021/acsomega.0c01818 · Cited by 707
Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects
Tang, S.-M., Deng, X.-T., Zhou, J., Li, Q.-P., Ge, X.-X., & Miao, L. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109604 · Cited by 654
A review on anti-cancer properties of Quercetin in breast cancer
Ezzati, M., Yousefi, B., Velaei, K., & Safa, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117463 · Cited by 356
Metadata
- Authors
- Jia, L., Huang, S., Yin, X., Zan, Y., Guo, Y., & Han, L.
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 208
- Pages
- 123-130
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W2884744510
- Cited by
- 304
- References
- 27
- FWCI
- 14.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.